Author

D. Nyayanit

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 7 Research Focus:host-pathogen & immune response· 7 Organism:human· 3 Organism:mouse· 3 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

P. Yadav· 6 shared N. Gupta· 5 shared P. Abraham· 5 shared P. Sarkale· 5 shared A. Shete· 4 shared G. Deshpande· 4 shared S. Kumar· 4 shared S. Mohandas· 4 shared

Activity by Year

2021-2021 · peak 7/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersMicrobiology

P. Yadav

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model

P. Yadav, S. Mohandas, P. Sarkale, D. Nyayanit, A. Shete, R. Sahay, V. Potdar, S. Baradkar, N. Gupta, G. Sapkal, P. Abraham, S. Panda, B. Bhargava

The paper isolates the SARS-CoV-2 B.1.1.28.2 (P.2) variant from travelers and compares its pathogenicity to the D614G variant in hamsters, finding it more severe and with reduced neutralization.

bioRxiv · May 24, 2021Microbiology

Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelers

P. Yadav, P. Sarkale, A. Razdan, N. Gupta, D. Nyayanit, R. Sahay, V. Potdar, D. Patil, S. Baradkar, A. Kumar, N. Aggarwal, A. Shete, H. Kaur

The paper isolates and characterizes the SARS-CoV-2 VOC 20H/501Y.V2 (B.1.351) from UAE travelers to India to assess vaccine efficacy.

bioRxiv · May 14, 2021 · PreprintMicrobiology

Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1

P. Yadav, G. N. Sapkal, P. Abraham, G. Deshpande, D. Nyayanit, D. Y. Patil, N. Gupta, R. R. Sahay, A. Shete, S. Kumar, S. Panda, B. Bhargava

This study compares neutralizing antibody responses in Covishield-vaccinated individuals and COVID-19 recovered subjects against B.1 and B.1.617.1 variants, finding higher neutralization in recovered subjects.

bioRxiv · May 12, 2021Immunology

Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees

P. Yadav, G. N. Sapkal, P. Abraham, R. Ella, G. Deshpande, D. Y. Patil, D. Nyayanit, N. Gupta, R. R. Sahay, A. M. Shete, S. Panda, B. Bhargava, V. K. Mohan

The paper assesses the neutralizing ability of sera from BBV152 vaccinees and convalescent COVID-19 patients against B.1.617 variants.

bioRxiv · Apr 23, 2021Immunology

Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters

S. Mohandas, P. Yadav, D. Nyayanit, A. Shete-Aich, P. Sarkale, S. Hundekar, S. Kumar, K. Lole

This study compares the transmission efficiency of SARS-CoV-2 UK variant and D614G variant in Syrian hamsters via different routes, finding comparable transmission between the two variants.

bioRxiv · Mar 26, 2021Microbiology

Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model

S. Mohandas, P. D. Yadav, D. Nyayanit, G. Deshpande, A. S. Aich, G. Sapkal, S. Kumar, R. Jain, M. Kadam, A. Kumar, D. Y. Patil, P. Sarkale, P. Gawande, P. Abraham

This study compares the pathogenicity and virus shedding of SARS-CoV-2 VOC 202012/01 and D614G variants in hamsters, finding higher viral shedding and mild lung pathology with VOC 202012/01.

bioRxiv · Feb 25, 2021 · PreprintMicrobiology

Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection

P. Yadav, S. Kumar, K. Agarwal, M. Jain, D. Patil, K. Maithal, B. Mathapati, S. Giri, S. Mohandas, A. Shete, G. Sapkal, D. Patil, A. Dey, H. Chandra, G. Deshpande, , P. Abraham

This study evaluates two doses of ZyCoV-D DNA vaccine in rhesus macaques, finding that the 2mg dose via Needle Free Injection System provides better immune response and protection against SARS-CoV-2.

bioRxiv · Feb 2, 2021 · PreprintMicrobiology